Aaron Lee, MD, an associate professor of ophthalmology at the University of Washington, discusses some limitations of artificial intelligence (AI) in the ophthalmology field.
Artificial intelligence (AI) can't do the full spectrum of all the things a human clinician does today, said Aaron Lee, MD, an associate professor of ophthalmology at the University of Washington.
Transcript
Can you discuss some of the pitfalls resulting from the transition to digital care in ophthalmology?
I do worry a little bit about the hype around AI, because so much of AI has elevated everybody's expectations. We expect AI to be able to drive our cars. We expect AI to keep airplanes in the air and all those kinds of things. And it is true that this technology, specifically deep learning, is a remarkable advancement in artificial intelligence. It is true that it is capable of some wondrous things, things that I thought were completely impossible before. But it comes with very important caveats.
They're very, very good at a very narrow window of things. So I think people may not understand, both clinicians as well as patients, that an AI algorithm being used in their care may only be useful in that very narrow context. Now, in that context, it may do an amazing job, but it can't do the full spectrum of all the things that a human clinician can do today.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More